1. Home
  2. ZLAB vs SGHC Comparison

ZLAB vs SGHC Comparison

Compare ZLAB & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SGHC
  • Stock Information
  • Founded
  • ZLAB 2013
  • SGHC 2020
  • Country
  • ZLAB China
  • SGHC Guernsey
  • Employees
  • ZLAB N/A
  • SGHC N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SGHC Services-Misc. Amusement & Recreation
  • Sector
  • ZLAB Health Care
  • SGHC Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • SGHC Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • SGHC 3.9B
  • IPO Year
  • ZLAB 2017
  • SGHC N/A
  • Fundamental
  • Price
  • ZLAB $29.24
  • SGHC $8.27
  • Analyst Decision
  • ZLAB Buy
  • SGHC Strong Buy
  • Analyst Count
  • ZLAB 4
  • SGHC 5
  • Target Price
  • ZLAB $47.37
  • SGHC $11.00
  • AVG Volume (30 Days)
  • ZLAB 1.2M
  • SGHC 825.2K
  • Earning Date
  • ZLAB 05-08-2025
  • SGHC 05-08-2025
  • Dividend Yield
  • ZLAB N/A
  • SGHC 3.50%
  • EPS Growth
  • ZLAB N/A
  • SGHC 277.96
  • EPS
  • ZLAB N/A
  • SGHC 0.27
  • Revenue
  • ZLAB $418,326,000.00
  • SGHC $1,939,039,555.00
  • Revenue This Year
  • ZLAB $44.43
  • SGHC $15.33
  • Revenue Next Year
  • ZLAB $48.68
  • SGHC $10.22
  • P/E Ratio
  • ZLAB N/A
  • SGHC $30.67
  • Revenue Growth
  • ZLAB 43.72
  • SGHC 21.48
  • 52 Week Low
  • ZLAB $15.65
  • SGHC $2.91
  • 52 Week High
  • ZLAB $39.77
  • SGHC $8.51
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 42.71
  • SGHC 56.82
  • Support Level
  • ZLAB $27.61
  • SGHC $8.47
  • Resistance Level
  • ZLAB $32.02
  • SGHC $9.17
  • Average True Range (ATR)
  • ZLAB 1.23
  • SGHC 0.34
  • MACD
  • ZLAB -0.18
  • SGHC 0.05
  • Stochastic Oscillator
  • ZLAB 23.41
  • SGHC 44.10

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

Share on Social Networks: